The DOI matches its Crossref record; 340 of the 340 references it cites were found in a registry or an index.
Infectious Diseases Society of America 2022 Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa)
Open accessAbstract
Background: The Infectious Diseases Society of America (IDSA) is committed to providing up-to-date guidance on the treatment of antimicrobial-resistant infections. The initial guidance document on infections caused by extended-spectrum β-lactamase producing Enterobacterales (ESBL-E), carbapenem-resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with difficult-to-treat resistance (DTR-P. aeruginosa) was published on 17 September 2020. Over the past year, there have been a number of important publications furthering our understanding of the management of ESBL-E, CRE, and DTR-P. aeruginosa infections, prompting a rereview of the literature and this updated guidance document. Methods: A panel of 6 infectious diseases specialists with expertise in managing antimicrobial-resistant infections reviewed, updated, and expanded previously developed questions and recommendations about the treatment of ESBL-E, CRE, and DTR-P. aeruginosa infections. Because of differences in the epidemiology of resistance and availability of specific anti-infectives internationally, this document focuses on the treatment of infections in the United States. Results: Preferred and alternative treatment recommendations are provided with accompanying rationales, assuming the causative organism has been identified and antibiotic susceptibility results are known. Approaches to empiric treatment, duration of therapy, and other management considerations are also discussed briefly. Recommendations apply for both adult and pediatric populations. Conclusions: The field of antimicrobial resistance is highly dynamic. Consultation with an infectious diseases specialist is recommended for the treatment of antimicrobial-resistant infections. This document is current as of 24 October 2021. The most current versions of IDSA documents, including dates of publication, are available at www.idsociety.org/practice-guideline/amr-guidance/.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Magiorakos, A.-P., Srinivasan, A., Carey, R. B., Carmeli, Y., Falagas, M. E., Giske, C. G., Harbarth, S., Hindler, J. F., Kahlmeter, G., Olsson-Liljequist, B., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03570.x · Cited by 14,449
Antibiotic resistance threats in the United States, 2019
(U.S.), C. F. D. C. A. P. (2019) · doi:10.15620/cdc:82532 · Cited by 5,782
Kalil, A. C., Metersky, M. L., Klompas, M., Muscedere, J., Sweeney, D. A., Palmer, L. B., Napolitano, L. M., O'Grady, N. P., Bartlett, J. G., Carratalà, J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw353 · Cited by 3,892
Gupta, K., Hooton, T. M., Naber, K. G., Wullt, B., Colgan, R., Miller, L. G., Moran, G. J., Nicolle, L. E., Raz, R., Schaeffer, A. J., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq257 · Cited by 3,038
Updated Functional Classification of β-Lactamases
Bush, K., & Jacoby, G. A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01009-09 · Cited by 2,367
Lister, P. D., Wolter, D. J., & Hanson, N. D. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00040-09 · Cited by 1,789
Pepin, J., Saheb, N., Coulombe, M.-A., Alary, M.-E., Corriveau, M.-P., Authier, S., Leblanc, M., Rivard, G., Bettez, M., Primeau, V., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/496986 · Cited by 995
Tsuji, B. T., Pogue, J. M., Zavascki, A. P., Paul, M., Daikos, G. L., Forrest, A., Giacobbe, D. R., Viscoli, C., Giamarellou, H., Karaiskos, I., et al. (2019) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2209 · Cited by 949
Epidemiology of β-Lactamase-Producing Pathogens
Bush, K., & Bradford, P. A. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00047-19 · Cited by 938
Combination Therapy for Treatment of Infections with Gram-Negative Bacteria
Tamma, P. D., Cosgrove, S. E., & Maragakis, L. L. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.05041-11 · Cited by 836
Self-citationBassetti, M., Echols, R., Matsunaga, Y., Ariyasu, M., Doi, Y., Ferrer, R., Lodise, T. P., Naas, T., Niki, Y., Paterson, D. L., et al. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30796-9 · Cited by 828
Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines
Agwuh, K. N. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl224 · Cited by 806
Extended-spectrum β-lactamases: an update on their characteristics, epidemiology and detection
Castanheira, M., Simner, P. J., & Bradford, P. A. (2021) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlab092 · Cited by 796
Harris, P. N. A., Tambyah, P. A., Lye, D. C., Mo, Y., Lee, T. H., Yilmaz, M., Alenazi, T. H., Arabi, Y., Falcone, M., Bassetti, M., et al. (2018) · JAMA · doi:10.1001/jama.2018.12163 · Cited by 774
van Duin, D., Lok, J. J., Earley, M., Cober, E., Richter, S. S., Perez, F., Salata, R. A., Kalayjian, R. C., Watkins, R. R., Doi, Y., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/cix783 · Cited by 655
Self-citationKadri, S. S., Adjemian, J., Lai, Y. L., Spaulding, A. B., Ricotta, E., Prevots, D. R., Palmore, T. N., Rhee, C., Klompas, M., Dekker, J. P., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy378 · Cited by 605
Daikos, G. L., Tsaousi, S., Tzouvelekis, L. S., Anyfantis, I., Psichogiou, M., Argyropoulou, A., Stefanou, I., Sypsa, V., Miriagou, V., Nepka, M., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02166-13 · Cited by 597
Meta-Analysis of Antibiotics and the Risk of Community-Associated Clostridium difficile Infection
Brown, K. A., Khanafer, N., Daneman, N., & Fisman, D. N. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02176-12 · Cited by 587
Multidrug-resistant bacterial infections in U.S. hospitalized patients, 2012-2017.
Jernigan, J. A., Hatfield, K. M., Wolford, H., Nelson, R. E., Olubajo, B., Reddy, S. C., McCarthy, N., Paul, P., McDonald, L. C., Kallen, A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1914433 · Cited by 577
Interplay between β-lactamases and new β-lactamase inhibitors
Bush, K., & Bradford, P. A. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0159-8 · Cited by 531
Shields, R. K., Nguyen, M. H., Chen, L., Press, E. G., Potoski, B. A., Marini, R. V., Doi, Y., Kreiswirth, B. N., & Clancy, C. J. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00883-17 · Cited by 495
Self-citationShields, R. K., Chen, L., Cheng, S., Chavda, K. D., Press, E. G., Snyder, A., Pandey, R., Doi, Y., Kreiswirth, B. N., Nguyen, M. H., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02097-16 · Cited by 484
Self-citationWunderink, R. G., Giamarellos-Bourboulis, E. J., Rahav, G., Mathers, A. J., Bassetti, M., Vazquez, J., Cornely, O. A., Solomkin, J., Bhowmick, T., Bishara, J., et al. (2018) · Infectious Diseases and Therapy · doi:10.1007/s40121-018-0214-1 · Cited by 461
Self-citationTorres, A., Zhong, N., Pachl, J., Timsit, J.-F., Kollef, M., Chen, Z., Song, J., Taylor, D., Laud, P. J., Stone, G. G., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30747-8 · Cited by 441
Sandri, A. M., Landersdorfer, C. B., Jacob, J., Boniatti, M. M., Dalarosa, M. G., Falci, D. R., Behle, T. F., Bordinhão, R. C., Wang, J., Forrest, A., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit334 · Cited by 430
Shields, R. K., Potoski, B. A., Haidar, G., Hao, B., Doi, Y., Chen, L., Press, E. G., Kreiswirth, B. N., Clancy, C. J., & Nguyen, M. H. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw636 · Cited by 430
Self-citationMotsch, J., Murta de Oliveira, C., Stus, V., Köksal, I., Lyulko, O., Boucher, H. W., Kaye, K. S., File, T. M., Brown, M. L., Khan, I., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciz530 · Cited by 422
Solomkin, J., Hershberger, E., Miller, B., Popejoy, M., Friedland, I., Steenbergen, J., Yoon, M., Collins, S., Yuan, G., Barie, P. S., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ097 · Cited by 420
Portsmouth, S., van Veenhuyzen, D., Echols, R., Machida, M., Ferreira, J. C. A., Ariyasu, M., Tenke, P., & Nagata, T. D. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30554-1 · Cited by 420
Kalil, A. C., Metersky, M. L., Klompas, M., Muscedere, J., Sweeney, D. A., Palmer, L. B., Napolitano, L. M., O'Grady, N. P., Bartlett, J. G., Carratalà, J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw504 · Cited by 419
Carmeli, Y., Armstrong, J., Laud, P. J., Newell, P., Stone, G., Wardman, A., & Gasink, L. B. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)30004-4 · Cited by 417
Tamma, P. D., Goodman, K. E., Harris, A. D., Tekle, T., Roberts, A., Taiwo, A., & Simner, P. J. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw741 · Cited by 402
Self-citationIto, A., Sato, T., Ota, M., Takemura, M., Nishikawa, T., Toba, S., Kohira, N., Miyagawa, S., Ishibashi, N., Matsumoto, S., et al. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01454-17 · Cited by 400
Mazuski, J. E., Gasink, L. B., Armstrong, J., Broadhurst, H., Stone, G. G., Rank, D., Llorens, L., Newell, P., & Pachl, J. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw133 · Cited by 393
Wagenlehner, F. M., Umeh, O., Steenbergen, J., Yuan, G., & Darouiche, R. O. (2015) · The Lancet · doi:10.1016/s0140-6736(14)62220-0 · Cited by 388
Babinchak, T., Ellis‐Grosse, E., Dartois, N., Rose, G. M., Loh, E., & Groups, T. 3. A. 3. S. (2005) · Clinical Infectious Diseases · doi:10.1086/431676 · Cited by 381
Falcone, M., Daikos, G. L., Tiseo, G., Bassoulis, D., Giordano, C., Galfo, V., Leonildi, A., Tagliaferri, E., Barnini, S., Sani, S., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa586 · Cited by 380
Rodriguez-Bano, J., Navarro, M. D., Retamar, P., Picon, E., Pascual, A., & the Extended-Spectrum Beta-Lactamases-Red Espanola de Investigacion en Patologia Infecciosa/Grupo de Estudio de Infeccion Hospitalaria Group (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir790 · Cited by 363
Wagenlehner, F. M., Sobel, J. D., Newell, P., Armstrong, J., Huang, X., Stone, G. G., Yates, K., & Gasink, L. B. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw378 · Cited by 362
Tumbarello, M., Trecarichi, E. M., Corona, A., De Rosa, F. G., Bassetti, M., Mussini, C., Menichetti, F., Viscoli, C., Campoli, C., Venditti, M., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy492 · Cited by 354
Lomovskaya, O., Sun, D., Rubio-Aparicio, D., Nelson, K., Tsivkovski, R., Griffith, D. C., & Dudley, M. N. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01443-17 · Cited by 353
Roberts, J. A., Kirkpatrick, C. M. J., Roberts, M. S., Robertson, T. A., Dalley, A. J., & Lipman, J. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp139 · Cited by 347
Kollef, M. H., Nováček, M., Kivistik, Ü., Réa-Neto, Á., Shime, N., Martin-Loeches, I., Timsit, J.-F., Wunderink, R. G., Bruno, C. J., Huntington, J. A., et al. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(19)30403-7 · Cited by 345
van Duin, D., Arias, C. A., Komarow, L., Chen, L., Hanson, B. M., Weston, G., Cober, E., Garner, O. B., Jacob, J. T., Satlin, M. J., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(19)30755-8 · Cited by 337
Self-citationsourmash: a library for MinHash sketching of DNA
Titus Brown, C., & Irber, L. (2016) · The Journal of Open Source Software · doi:10.21105/joss.00027 · Cited by 329
Boyd, S. E., Livermore, D. M., Hooper, D. C., & Hope, W. W. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00397-20 · Cited by 315
Tamma, P. D., Han, J. H., Rock, C., Harris, A. D., Lautenbach, E., Hsu, A. J., Avdic, E., & Cosgrove, S. E. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ003 · Cited by 314
Self-citationKaye, K. S., Bhowmick, T., Metallidis, S., Bleasdale, S. C., Sagan, O. S., Stus, V., Vazquez, J., Zaitsev, V., Bidair, M., Chorvat, E., et al. (2018) · JAMA · doi:10.1001/jama.2018.0438 · Cited by 314
Phenotypic Detection of Carbapenemase-Producing Organisms from Clinical Isolates
Tamma, P. D., & Simner, P. J. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.01140-18 · Cited by 293
Self-citationShields, R. K., Nguyen, M. H., Chen, L., Press, E. G., Kreiswirth, B. N., & Clancy, C. J. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02497-17 · Cited by 289
Self-citationHaidar, G., Philips, N. J., Shields, R. K., Snyder, D., Cheng, S., Potoski, B. A., Doi, Y., Hao, B., Press, E. G., Cooper, V. S., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix182 · Cited by 277
Self-citationSolomkin, J., Evans, D., Slepavicius, A., Lee, P., Marsh, A., Tsai, L., Sutcliffe, J. A., & Horn, P. (2017) · JAMA Surgery · doi:10.1001/jamasurg.2016.4237 · Cited by 276
Tumbarello, M., Raffaelli, F., Giannella, M., Mantengoli, E., Mularoni, A., Venditti, M., De Rosa, F. G., Sarmati, L., Bassetti, M., Brindicci, G., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab176 · Cited by 275
Kinetic interactions of tazobactam with beta-lactamases from all major structural classes
Bush, K., Macalintal, C., Rasmussen, B. A., Lee, V. J., & Yang, Y. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.4.851 · Cited by 274
Berrazeg, M., Jeannot, K., Ntsogo Enguéné, V. Y., Broutin, I., Loeffert, S., Fournier, D., & Plésiat, P. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00825-15 · Cited by 268
Efficacy and safety of tigecycline: a systematic review and meta-analysis
Yahav, D., Lador, A., Paul, M., & Leibovici, L. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr242 · Cited by 266
First Report of Ceftazidime-Avibactam Resistance in a KPC-3-Expressing Klebsiella pneumoniae Isolate
Humphries, R. M., Yang, S., Hemarajata, P., Ward, K. W., Hindler, J. A., Miller, S. A., & Gregson, A. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01165-15 · Cited by 255
Cabot, G., Bruchmann, S., Mulet, X., Zamorano, L., Moyà, B., Juan, C., Haussler, S., & Oliver, A. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02462-13 · Cited by 247
De Pascale, G., Montini, L., Pennisi, M. A., Bernini, V., Maviglia, R., Bello, G., Spanu, T., Tumbarello, M., & Antonelli, M. (2014) · Critical Care · doi:10.1186/cc13858 · Cited by 245
Hackel, M. A., Tsuji, M., Yamano, Y., Echols, R., Karlowsky, J. A., & Sahm, D. F. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01968-17 · Cited by 235
Titov, I., Wunderink, R. G., Roquilly, A., Rodríguez Gonzalez, D., David-Wang, A., Boucher, H. W., Kaye, K. S., Losada, M. C., Du, J., Tipping, R., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa803 · Cited by 226
Solomkin, J. S., Gardovskis, J., Lawrence, K., Montravers, P., Sway, A., Evans, D., & Tsai, L. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy1029 · Cited by 222
Giddins, M. J., Macesic, N., Annavajhala, M. K., Stump, S., Khan, S., McConville, T. H., Mehta, M., Gomez-Simmonds, A., & Uhlemann, A.-C. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02101-17 · Cited by 219
Once-Daily Plazomicin for Complicated Urinary Tract Infections
Wagenlehner, F. M. E., Cloutier, D. J., Komirenko, A. S., Cebrik, D. S., Krause, K. M., Keepers, T. R., Connolly, L. E., Miller, L. G., Friedland, I., & Dwyer, J. P. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1801467 · Cited by 218
Huttner, A., Kowalczyk, A., Turjeman, A., Babich, T., Brossier, C., Eliakim-Raz, N., Kosiek, K., Martinez de Tejada, B., Roux, X., Shiber, S., et al. (2018) · JAMA · doi:10.1001/jama.2018.3627 · Cited by 214
Boisson, M., Jacobs, M., Grégoire, N., Gobin, P., Marchand, S., Couet, W., & Mimoz, O. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03510-14 · Cited by 211
Rattanaumpawan, P., Lorsutthitham, J., Ungprasert, P., Angkasekwinai, N., & Thamlikitkul, V. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq360 · Cited by 211
Michalopoulos, A., Kasiakou, S. K., Mastora, Z., Rellos, K., Kapaskelis, A. M., & Falagas, M. E. (2004) · Critical Care · doi:10.1186/cc3020 · Cited by 209
Lu, Q., Luo, R., Bodin, L., Yang, J., Zahr, N., Aubry, A., Golmard, J.-L., & Rouby, J.-J. (2012) · Anesthesiology · doi:10.1097/aln.0b013e31827515de · Cited by 207
Kofteridis, D. P., Alexopoulou, C., Valachis, A., Maraki, S., Dimopoulou, D., Georgopoulos, D., & Samonis, G. (2010) · Clinical Infectious Diseases · doi:10.1086/657242 · Cited by 207
Fraile-Ribot, P. A., Cabot, G., Mulet, X., Periañez, L., Martín-Pena, M. L., Juan, C., Pérez, J. L., & Oliver, A. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx424 · Cited by 207
Pogue, J. M., Kaye, K. S., Veve, M. P., Patel, T. S., Gerlach, A. T., Davis, S. L., Puzniak, L. A., File, T. M., Olson, S., Dhar, S., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciz816 · Cited by 206
Self-citationAkajagbor, D. S., Wilson, S. L., Shere-Wolfe, K. D., Dakum, P., Charurat, M. E., & Gilliam, B. L. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit453 · Cited by 205
Widespread Fosfomycin Resistance in Gram-Negative Bacteria Attributable to the Chromosomal fosA Gene
Ito, R., Mustapha, M. M., Tomich, A. D., Callaghan, J. D., McElheny, C. L., Mettus, R. T., Shanks, R. M. Q., Sluis-Cremer, N., & Doi, Y. (2017) · mBio · doi:10.1128/mbio.00749-17 · Cited by 204
Hackel, M. A., Tsuji, M., Yamano, Y., Echols, R., Karlowsky, J. A., & Sahm, D. F. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00093-17 · Cited by 202
Emergence of ceftazidime/avibactam resistance in carbapenem-resistant Klebsiella pneumoniae in China
Zhang, P., Shi, Q., Hu, H., Hong, B., Wu, X., Du, X., Akova, M., & Yu, Y. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.08.020 · Cited by 200
Use of Monte Carlo Simulation to Design an Optimized Pharmacodynamic Dosing Strategy for Meropenem
Kuti, J. L., Dandekar, P. K., Nightingale, C. H., & Nicolau, D. P. (2003) · The Journal of Clinical Pharmacology · doi:10.1177/0091270003257225 · Cited by 199
Karlowsky, J. A., Kazmierczak, K. M., de Jonge, B. L. M., Hackel, M. A., Sahm, D. F., & Bradford, P. A. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00472-17 · Cited by 194
Kazmierczak, K. M., Tsuji, M., Wise, M. G., Hackel, M., Yamano, Y., Echols, R., & Sahm, D. F. (2019) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2018.10.007 · Cited by 193
Short-Course Nitrofurantoin for the Treatment of Acute Uncomplicated Cystitis in Women
Gupta, K. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.20.2207 · Cited by 192
Michalopoulos, A., Fotakis, D., Virtzili, S., Vletsas, C., Raftopoulou, S., Mastora, Z., & Falagas, M. E. (2008) · Respiratory Medicine · doi:10.1016/j.rmed.2007.10.011 · Cited by 191
Kwa, A. L. H., Loh, C., Low, J. G. H., Kurup, A., & Tam, V. H. (2005) · Clinical Infectious Diseases · doi:10.1086/432583 · Cited by 191
Polymyxin B: similarities to and differences from colistin (polymyxin E)
Kwa, A., Kasiakou, S. K., Tam, V. H., & Falagas, M. E. (2007) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.5.5.811 · Cited by 190
Zanetti, G., Bally, F., Greub, G., Garbino, J., Kinge, T., Lew, D., Romand, J.-A., Bille, J., Aymon, D., Stratchounski, L., et al. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.11.3442-3447.2003 · Cited by 190
Sandberg, T., Skoog, G., Hermansson, A. B., Kahlmeter, G., Kuylenstierna, N., Lannergård, A., Otto, G., Settergren, B., & Ekman, G. S. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60608-4 · Cited by 189
The Use of Noncarbapenem β-Lactams for the Treatment of Extended-Spectrum β-Lactamase Infections
Tamma, P. D., & Rodriguez-Baňo, J. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix034 · Cited by 186
Self-citationHooton, T. M., Scholes, D., Gupta, K., Stapleton, A. E., Roberts, P. L., & Stamm, W. E. (2005) · JAMA · doi:10.1001/jama.293.8.949 · Cited by 185
Tumbarello, M., De Pascale, G., Trecarichi, E. M., De Martino, S., Bello, G., Maviglia, R., Spanu, T., & Antonelli, M. (2013) · Chest · doi:10.1378/chest.13-1018 · Cited by 182
Lucasti, C., Vasile, L., Sandesc, D., Venskutonis, D., McLeroth, P., Lala, M., Rizk, M. L., Brown, M. L., Losada, M. C., Pedley, A., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00633-16 · Cited by 182
Activity of Imipenem with Relebactam against Gram-Negative Pathogens from New York City
Lapuebla, A., Abdallah, M., Olafisoye, O., Cortes, C., Urban, C., Landman, D., & Quale, J. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00830-15 · Cited by 181
Phe, K., Lee, Y., McDaneld, P. M., Prasad, N., Yin, T., Figueroa, D. A., Musick, W. L., Cottreau, J. M., Hu, M., & Tam, V. H. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02476-13 · Cited by 180
Castanheira, M., Farrell, S. E., Krause, K. M., Jones, R. N., & Sader, H. S. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01896-13 · Cited by 177
Lee, N.-Y., Lee, C.-C., Huang, W.-H., Tsui, K.-C., Hsueh, P.-R., & Ko, W.-C. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cis916 · Cited by 175
Kollef, M. H., Ricard, J.-D., Roux, D., Francois, B., Ischaki, E., Rozgonyi, Z., Boulain, T., Ivanyi, Z., János, G., Garot, D., et al. (2017) · Chest · doi:10.1016/j.chest.2016.11.026 · Cited by 173
Population Pharmacokinetic Analysis and Dosing Regimen Optimization of Meropenem in Adult Patients
Li, C., Kuti, J. L., Nightingale, C. H., & Nicolau, D. P. (2006) · The Journal of Clinical Pharmacology · doi:10.1177/0091270006291035 · Cited by 171
Korbila, I. P., Michalopoulos, A., Rafailidis, P. I., Nikita, D., Samonis, G., & Falagas, M. E. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.03040.x · Cited by 170
Ackley, R., Roshdy, D., Meredith, J., Minor, S., Anderson, W. E., Capraro, G. A., & Polk, C. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02313-19 · Cited by 170
Rello, J., Solé-Lleonart, C., Rouby, J.-J., Chastre, J., Blot, S., Poulakou, G., Luyt, C.-E., Riera, J., Palmer, L. B., Pereira, J. M., et al. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.04.011 · Cited by 167
Livermore, D. M., Warner, M., Jamrozy, D., Mushtaq, S., Nichols, W. W., Mustafa, N., & Woodford, N. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00678-15 · Cited by 166
Sims, M., Mariyanovski, V., McLeroth, P., Akers, W., Lee, Y.-C., Brown, M. L., Du, J., Pedley, A., Kartsonis, N. A., & Paschke, A. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx139 · Cited by 166
Sun, D., Rubio-Aparicio, D., Nelson, K., Dudley, M. N., & Lomovskaya, O. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01694-17 · Cited by 166
Motaouakkil, S., Charra, B., Hachimi, A., Nejmi, H., Benslama, A., Elmdaghri, N., Belabbes, H., & Benbachir, M. (2006) · Journal of Infection · doi:10.1016/j.jinf.2005.11.019 · Cited by 165
New Perspectives on Antimicrobial Agents: Cefiderocol
McCreary, E. K., Heil, E. L., & Tamma, P. D. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02171-20 · Cited by 165
Self-citationde Jonge, B. L. M., Karlowsky, J. A., Kazmierczak, K. M., Biedenbach, D. J., Sahm, D. F., & Nichols, W. W. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03042-15 · Cited by 162
Henderson, A., Paterson, D. L., Chatfield, M. D., Tambyah, P. A., Lye, D. C., De, P. P., Lin, R. T. P., Chew, K. L., Yin, M., Lee, T. H., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1479 · Cited by 161
Gutiérrez‐Gutiérrez, B., Pérez-Galera, S. I., Salamanca, E., de Cueto, M., Calbo, E., Almirante, B., Viale, P., Oliver, A., Pintado, V., Gasch, O., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00365-16 · Cited by 160
Self-citationTamma, P. D., Conley, A. T., Cosgrove, S. E., Harris, A. D., Lautenbach, E., Amoah, J., Avdic, E., Tolomeo, P., Wise, J., Subudhi, S., et al. (2019) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2018.6226 · Cited by 160
Self-citationShaw, E., Rombauts, A., Tubau, F., Padullés, A., Càmara, J., Lozano, T., Cobo-Sacristán, S., Sabe, N., Grau, I., Rigo-Bonnin, R., et al. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx496 · Cited by 159
Use of colistin in the treatment of multiple-drug-resistant gram-negative infections
Berlana, D., Llop, J. M., Casamartina, E. F., Badia, M., & Jódar, R. (2005) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/62.1.39 · Cited by 155
Castón, J. J., Lacort-Peralta, I., Martín‐Dávila, P., Loeches, B., Tabares, S., Temkin, L., Torre‐Cisneros, J., & Paño‐Pardo, J. R. (2017) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2017.03.021 · Cited by 154
Inhaled Antibiotics for Gram-Negative Respiratory Infections
Wenzler, E., Fraidenburg, D. R., Scardina, T. L., & Danziger, L. H. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00101-15 · Cited by 151
The epidemiology of carbapenemases in Latin America and the Caribbean
Escandón-Vargas, K., Reyes, S., Gutiérrez, S., & Villegas, M. V. (2016) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2017.1268918 · Cited by 151
Dobias, J., Tendon, V. D., Poirel, L., & Nordmann, P. (2017) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-017-3063-z · Cited by 151
Tuon, F. F., Rigatto, M. H., Lopes, C. K., Kamei, L. K., Rocha, J. L. L., & Zavascki, A. P. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.12.002 · Cited by 150
Karlowsky, J. A., Hackel, M., Tsuji, M., Yamano, Y., ECHOLS, R. M., & Sahm, D. F. (2018) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2018.11.007 · Cited by 149
Livermore, D. M., Andrews, J. M., Hawkey, P. M., Ho, P., Keness, Y., Doi, Y., Paterson, D. L., & Woodford, N. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks088 · Cited by 148
Abdellatif, S., Trifi, A., Daly, F., Mahjoub, K., Nasri, R., & Lakhal, S. B. (2016) · Annals of Intensive Care · doi:10.1186/s13613-016-0127-7 · Cited by 148
Lapuebla, A., Abdallah, M., Olafisoye, O., Cortes, C. D., Urban, C. M., Quale, J. M., & Landman, D. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00843-15 · Cited by 147
Rigatto, M. H., de Oliveira, M. S., Neto, L. V. P., Levin, A. S., Carrilho, C. M. D. D. M., Tanita, M. T., Tuon, F. F., Cardoso, D. E., Lopes, N. T., Falci, D. R., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02634-15 · Cited by 145
Haidar, G., Clancy, C. J., Chen, L., Samanta, P., Shields, R. K., Kreiswirth, B. N., & Nguyen, M. H. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00642-17 · Cited by 142
Self-citationCastanheira, M., Mills, J. C., Farrell, D. J., & Jones, R. N. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03681-14 · Cited by 141
Sader, H. S., Huband, M. D., Castanheira, M., & Flamm, R. K. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02252-16 · Cited by 141
Winkler, M., Papp‐Wallace, K. M., & Bonomo, R. A. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv094 · Cited by 140
Self-citationLob, S. H., Hackel, M., Kazmierczak, K. M., Young, K., Motyl, M. R., Karlowsky, J. A., & Sahm, D. F. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02209-16 · Cited by 140
Castanheira, M., Rhomberg, P. R., Flamm, R. K., & Jones, R. N. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00711-16 · Cited by 135
FDA adds "black box" warning label to fluoroquinolone antibiotics
Tanne, J. H. (2008) · BMJ · doi:10.1136/bmj.a816 · Cited by 133
Ng, T. M., Khong, W. X. L., Harris, P. N. A., De, P. P., Chow, A. L., Tambyah, P. A., & Lye, D. C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153696 · Cited by 133
Niederman, M. S., Alder, J. D., Bassetti, M., Boateng, F., Cao, B., Corkery, K. J., Dhand, R., Kaye, K. S., Lawatscheck, R., McLeroth, P., et al. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(19)30574-2 · Cited by 132
Resistance to Novel β-Lactam–β-Lactamase Inhibitor Combinations
Papp‐Wallace, K. M., Mack, A. R., Taracila, M. A., & Bonomo, R. A. (2020) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2020.05.001 · Cited by 130
Self-citationLahiri, S. D., Walkup, G. K., Whiteaker, J. D., Palmer, T., McCormack, K., Tanudra, M. A., Nash, T. J., Thresher, J., Johnstone, M. R., Hajec, L., et al. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv004 · Cited by 129
Matsumura, Y., Yamamoto, M., Nagao, M., Komori, T., Fujita, N., Hayashi, A., Shimizu, T., Watanabe, H., Doi, S., Tanaka, M., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00701-15 · Cited by 129
Sader, H. S., Castanheira, M., Flamm, R. K., Farrell, D. J., & Jones, R. N. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02429-13 · Cited by 129
Zha, L., Pan, L., Guo, J., French, N., Villanueva, E., & Tefsen, B. (2020) · Advances in Therapy · doi:10.1007/s12325-020-01235-y · Cited by 129
Livermore, D. M., Day, M. J., Cleary, P. R., Hopkins, K. L., Toleman, M. A., Wareham, D. W., Wiuff, C., Doumith, M., & Woodford, N. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky453 · Cited by 124
Falagas, M. E., Skalidis, T., Vardakas, K. Z., Legakis, N. J., & on behalf of the Hellenic Cefiderocol Study Group (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx049 · Cited by 122
Simner, P. J., Mostafa, H. H., Bergman, Y., Ante, M., Tekle, T., Adebayo, A., Beisken, S., Dzintars, K., & Tamma, P. D. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab888 · Cited by 121
Self-citationSader, H. S., Castanheira, M., Shortridge, D., Mendes, R. E., & Flamm, R. K. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01045-17 · Cited by 120
Walkty, A. J., Adam, H. J., Baxter, M. R., Denisuik, A. J., Lagacé-Wiens, P. R. S., Karlowsky, J. A., Hoban, D. J., & Zhanel, G. G. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02744-13 · Cited by 116
Goodlet, K. J., Benhalima, F. Z., & Nailor, M. D. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02165-18 · Cited by 116
Chopra, T., Marchaim, D., Veltman, J., Johnson, P., Zhao, J. J., Tansek, R., Hatahet, D., Chaudhry, K., Pogue, J. M., Hiro, R., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05419-11 · Cited by 115
Seo, Y. B., Lee, J., Kim, Y. K., Lee, S. S., Lee, J.-A., Kim, H. Y., Uh, Y., Kim, H.-S., & Song, W. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2502-x · Cited by 115
Lee, C.-H., Su, L.-H., Tang, Y., & Liu, J. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl381 · Cited by 114
LUCASTI, C. J., Hershberger, E., Miller, B. W., Yankelev, S., Steenbergen, J. N., Friedland, I. R., & Solomkin, J. S. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00049-14 · Cited by 114
Is Fosfomycin a Potential Treatment Alternative for Multidrug-Resistant Gram-Negative Prostatitis?
Gardiner, B. J., Mahony, A. A., Ellis, A. G., Lawrentschuk, N., Bolton, D. M., Zeglinski, P. T., Frauman, A. G., & Grayson, M. L. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit704 · Cited by 112
Tigecycline Treatment for Carbapenem-Resistant Enterobacteriaceae Infections
Ni, W., Han, Y., Liu, J., Wei, C., Zhao, J., Cui, J., Wang, R., & Liu, Y.-N. (2016) · Medicine · doi:10.1097/md.0000000000003126 · Cited by 112
Ceftazidime/avibactam resistance associated with L169P mutation in the omega loop of KPC-2
Hemarajata, P., & Humphries, R. M. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz026 · Cited by 112
Inhaled Antibiotic Therapy in Chronic Respiratory Diseases
Maselli, D. J., Keyt, H., & Restrepo, M. I. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18051062 · Cited by 107
Zhang, Y., Kashikar, A., Brown, C. A., Denys, G. A., & Bush, K. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00389-17 · Cited by 107
Papp‐Wallace, K. M., Barnes, M. D., Alsop, J., Taracila, M. A., Bethel, C. R., Becka, S. A., van Duin, D., Kreiswirth, B. N., Kaye, K. S., & Bonomo, R. A. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00174-18 · Cited by 107
Self-citationShields, R. K., McCreary, E. K., Marini, R. V., Kline, E. G., Jones, C. E., Hao, B., Chen, L., Kreiswirth, B. N., Doi, Y., Clancy, C. J., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz1131 · Cited by 106
Self-citationBiagi, M. J., Wu, T., Lee, M., Patel, S., Butler, D. A., & Wenzler, E. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01426-19 · Cited by 105
Kalın, G., Alp, E., Demiraslan, H., Doğanay, M., Coskun, R., & Gündoğan, K. (2012) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-012-0430-7 · Cited by 101
Compain, F., & Arthur, M. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00451-17 · Cited by 101
Morrissey, I., Olesky, M., Hawser, S., Lob, S. H., Karlowsky, J. A., Corey, G. R., Bassetti, M., & Fyfe, C. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01699-19 · Cited by 101
Karaiskos, I., Daikos, G. L., Gkoufa, A., Adamis, G., Stefos, A., Symbardi, S., Chrysos, G., Filiou, E., Basoulis, D., Mouloudi, E. K., et al. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaa503 · Cited by 101
Heil, E. L., Bork, J. T., Abbo, L. M., Barlam, T. F., Cosgrove, S. E., Davis, A. E., Ha, D. R., Jenkins, T. C., Kaye, K. S., Lewis, J. S., et al. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab434 · Cited by 100
Self-citationPolymyxin B and colistimethate are comparable as to efficacy and renal toxicity
de Oliveira, M. S., do Prado, G. V. B., Costa, S. F., Grinbaum, R. S., & Levin, A. S. (2009) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2009.07.018 · Cited by 99
Shields, R. K., Iovleva, A., Kline, E. G., Kawai, A., McElheny, C. L., & Doi, Y. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa355 · Cited by 99
Emergence of ceftazidime/avibactam resistance in KPC-3-producing Klebsiella pneumoniae in vivo
Göttig, S., Frank, D., Mungo, E., Nolte, A., Hogardt, M., Besier, S. M., & Wichelhaus, T. A. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz330 · Cited by 98
Pfaller, M. A., Bassetti, M., Duncan, L. R., & Castanheira, M. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx009 · Cited by 97
Pfaller, M. A., Huband, M. D., Mendes, R. E., Flamm, R. K., & Castanheira, M. (2018) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2018.02.021 · Cited by 96
Falagas, M. E., Kasiakou, S. K., Kofteridis, D. P., Roditakis, G., & Samonis, G. (2006) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-006-0191-2 · Cited by 95
Aerosolized Antibiotics for Ventilator-associated Pneumonia
Rouby, J., Bouhemad, B., Monsel, A., Brisson, H., Arbelot, C., & Lü, Q. (2012) · Anesthesiology · doi:10.1097/aln.0b013e3182755d7a · Cited by 95
Castanheira, M., Davis, A. P., Mendes, R. E., Serio, A. W., Krause, K. M., & Flamm, R. K. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00313-18 · Cited by 92
Ofer-Friedman, H., Shefler, C., Sharma, S., Tirosh, A., Tal-Jasper, R., Kandipalli, D., Sharma, S., Bathina, P., Kaplansky, T., Maskit, M., et al. (2015) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2015.101 · Cited by 91
Athans, V., Neuner, E. A., Hassouna, H., Richter, S. S., Keller, G., Castanheira, M., Brizendine, K. D., & Mathers, A. J. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01551-18 · Cited by 90
Self-citationRobberts, F. J. L., Kohner, P. C., & Patel, R. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.01687-08 · Cited by 89
Sader, H. S., Castanheira, M., Flamm, R. K., Mendes, R. E., Farrell, D. J., & Jones, R. N. (2015) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.02.022 · Cited by 89
Gaibani, P., Re, M. C., Campoli, C., Viale, P., & Ambretti, S. (2019) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.11.011 · Cited by 89
MacVane, S. H., Pandey, R., Steed, L. L., Kreiswirth, B. N., & Chen, L. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01183-17 · Cited by 88
Griffith, D. C., Sabet, M., Tarazi, Z., Lomovskaya, O., & Dudley, M. N. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01659-18 · Cited by 88
Fraile-Ribot, P. A., Zamorano, L., Orellana, R., del Barrio-Tofiño, E., Sánchez-Diener, I., Cortés-Lara, S., López-Causapé, C., Cabot, G., Bou, G., Martı́nez-Martı́nez, L., et al. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02165-19 · Cited by 87
Kawai, A., McElheny, C. L., Iovleva, A., Kline, E. G., Sluis‐Cremer, N., Shields, R. K., & Doi, Y. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00198-20 · Cited by 87
Shortridge, D., Castanheira, M., Pfaller, M. A., & Flamm, R. K. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00465-17 · Cited by 86
Karlowsky, J. A., Lob, S. H., Kazmierczak, K. M., Hawser, S., Magnet, S., Young, K., Motyl, M. R., & Sahm, D. F. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky107 · Cited by 86
Wilson, W. R., Kline, E. G., Jones, C. E., Morder, K. M., Mettus, R. T., Doi, Y., Nguyen, M. H., Clancy, C. J., & Shields, R. K. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02048-18 · Cited by 85
Self-citationDefining the Role of Novel β-Lactam Agents That Target Carbapenem-Resistant Gram-Negative Organisms
Tamma, P. D., & Hsu, A. J. (2019) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piz002 · Cited by 85
Self-citationEckmann, C., Montravers, P., Bassetti, M., Bodmann, K. ‐., Heizmann, W. R., García, M. S., Guirao, X., Capparella, M. R., Simoneau, D., & Dupont, H. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt142 · Cited by 84
Sader, H. S., Castanheira, M., Mendes, R. E., Flamm, R. K., Farrell, D. J., & Jones, R. N. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05024-14 · Cited by 83
la Calle, C. D., Rodríguez-Núñez, O., Morata, L., Marco, F., Cardozo, C., García‐Vidal, C., del Río, A., Fehér, C., Pellicé, M., Puerta‐Alcalde, P., et al. (2018) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2018.11.015 · Cited by 83
Punjabi, C. D., Tien, V., Meng, L., Deresinski, S. C., & Holubar, M. K. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofz364 · Cited by 83
Lodise, T. P., Smith, N. M., O’Donnell, J. N., Eakin, A. E., Holden, P. N., Boissonneault, K. R., Zhou, J., Tao, X., Bulitta, J. B., Fowler, V. G., et al. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaa197 · Cited by 83
Self-citationSader, H. S., Castanheira, M., Mendes, R. E., & Flamm, R. K. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky279 · Cited by 82
Alraddadi, B. M., Saeedi, M. F., Qutub, M., Alshukairi, A. N., Hassanien, A., & Wali, G. Y. (2019) · BMC Infectious Diseases · doi:10.1186/s12879-019-4409-1 · Cited by 82
Cefmetazole for bacteremia caused by ESBL-producing enterobacteriaceae comparing with carbapenems
Fukuchi, T., Iwata, K., Kobayashi, S., Nakamura, T., & Ohji, G. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-1770-1 · Cited by 81
Kazakova, S. V., Baggs, J. M., McDonald, L. C., Yi, S. H., Hatfield, K. M., Guh, A. Y., Reddy, S. C., & Jernigan, J. A. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz169 · Cited by 81
Doi, A., Shimada, T., Harada, S., Iwata, K., & Kamiya, T. (2012) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2012.09.010 · Cited by 80
Spiliopoulou, I. T., Kazmierczak, K. M., & Stone, G. G. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz456 · Cited by 80
Simner, P. J., Beisken, S., Bergman, Y., Posch, A. E., Cosgrove, S. E., & Tamma, P. D. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab311 · Cited by 80
Self-citationHakeam, H. A., Al-Sahli, H., Albabtain, L., Alassaf, S., Duhailib, Z. A., & Althawadi, S. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.05.079 · Cited by 80
Senchyna, F., Gaur, R. L., Sandlund, J., Truong, C., Tremintin, G., Kültz, D., Gómez, C. A., Tamburini, F. B., Andermann, T. M., Bhatt, A. S., et al. (2018) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2018.10.004 · Cited by 78
Streling, A. P., Al‐Obaidi, M. M., Lainhart, W., Zangeneh, T. T., Khan, A., Dinh, A. Q., Hanson, B., Arias, C. A., & Miller, W. R. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1909 · Cited by 78
Karlowsky, J. A., Kazmierczak, K. M., Bouchillon, S. K., DeJonge, B. L. M., Stone, G. G., & Sahm, D. F. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01814-18 · Cited by 77
Stone, G. G., Newell, P., Gasink, L. B., Broadhurst, H., Wardman, A., Yates, K., Chen, Z., Song, J., & Chow, J. W. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky204 · Cited by 77
Sharara, S. L., Amoah, J., Pana, Z. D., Simner, P. J., Cosgrove, S. E., & Tamma, P. D. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz1205 · Cited by 76
Self-citationDoshi, N., Cook, C. H., Mount, K. L., Stawicki, S. P., Frazee, E. N., Personett, H. A., Schramm, G. E., Arnold, H. M., & Murphy, C. V. (2013) · BMC Anesthesiology · doi:10.1186/1471-2253-13-45 · Cited by 75
Cañestro, M. D., Periañez, L., Mulet, X., Martín-Pena, M. L., Fraile-Ribot, P. A., Ayestarán, I., Colomar, A., Núñez, B., Macia, M. D., Novo, A., et al. (2018) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-018-3361-0 · Cited by 75
Castanheira, M., Doyle, T. B., Collingsworth, T. D., Sader, H. S., & Mendes, R. E. (2021) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkab306 · Cited by 75
Demırdal, T., Sarı, Ü. S., & Nemli, S. A. (2016) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-016-0123-7 · Cited by 74
Karlowsky, J. A., Lob, S. H., Raddatz, J. K., DePestel, D. D., Young, K., Motyl, M. R., & Sahm, D. F. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa381 · Cited by 74
Cited by
Karampatakis, T., Tsergouli, K., & Behzadi, P. (2023) · Antibiotics · doi:10.3390/antibiotics12020234 · Cited by 339
Pseudomonas aeruginosa: Infections, Animal Modeling, and Therapeutics
Wood, S. J., Kuzel, T. M., & Shafikhani, S. H. (2023) · Cells · doi:10.3390/cells12010199 · Cited by 254
Klebsiella pneumoniae carbapenemase variants: the new threat to global public health
Ding, L., Shen, S., Chen, J., Tian, Z., Shi, Q., Han, R., Guo, Y., & Hu, F. (2023) · Clinical Microbiology Reviews · doi:10.1128/cmr.00008-23 · Cited by 222
Rajakani, S. G., Xavier, B. B., Sey, A., Mariem, E. B., Lammens, C., Goossens, H., Glupczynski, Y., & Malhotra-Kumar, S. (2023) · Genes · doi:10.3390/genes14071426 · Cited by 17
Metadata
- Authors
- Tamma, P. D., Aitken, S. L., Bonomo, R. A., Mathers, A. J., van Duin, D., & Clancy, C. J.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2022-04-19
- Volume
- 75
- Issue
- 2
- Pages
- 187-212
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W4224266833
- Cited by
- 526
- References
- 340
- FWCI
- 29.43
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.